This inventor holds 1 USPTO granted patent. Top assignee: Tel Aviv University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Chen Benkler
Introduction
Chen Benkler is a notable inventor based in Tel Aviv, Israel. She has made significant strides in the field of medical treatments, particularly focusing on neurodegenerative disorders. Her work is characterized by a commitment to developing effective therapeutic methods for complex diseases.
Latest Patents
Chen Benkler holds a patent for a combination treatment for amyotrophic lateral sclerosis (ALS). This innovative method addresses various diseases, including emphysema, sepsis, and cognitive deficits. The patent describes a method that involves administering a therapeutically effective amount of a combination of at least two agents. One agent upregulates the activity and/or expression of Nrf2, while the second agent acts as a glutamatergic modulator, thereby providing a comprehensive treatment approach.
Career Highlights
Chen Benkler is affiliated with Tel Aviv University, where she contributes to research and development in the medical field. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from severe health conditions.
Collaborations
Chen collaborates with her coworker, Daniel Offen, who is also involved in innovative research. Their partnership enhances the scope and impact of their work in the medical community.
Conclusion
Chen Benkler's contributions to the field of medical innovation are noteworthy, particularly her patent for treating ALS and other related diseases. Her dedication to advancing therapeutic methods showcases the importance of research in improving patient care.